Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Characterization of the HIV-1 specific humoral immune response during highly active antiretroviral therapy (HAART)

Article Abstract:

The HIV-1-specific humoral immune response during highly active antiretroviral therapy (HAART) has been characterized using plasma samples from 19 patients. The factors involved in the high failure rate of HAART may include, in addition to emergence of HIV strains resistant to the drugs, this response. It may interact with both virus replication and drug therapy. A strong HIV-directed humoral immune response, as measured by V3 binding antibodies and neutralizing antibody responses before HAART, correlated with future viral suppression on HAART.

Author: Katzenstein, David A., Morris, Mary Kate, Israelski, Dennis, Zolopa, Andrew, Hendry, R. Michael, Hanson, Carl V.
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2001
Immunity, Immunity (Physiology), Highly active antiretroviral therapy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Amplification dynamics: predicting the effect of HIV on tuberculosis outbreaks

Article Abstract:

The effect of HIV on tuberculosis (TB) outbreaks and prediction of the effect are discussed with consideration of implications for global control and planned US elimination. A discrete event simulation model was used to predict the potential impact of HIV on increasing the probability and expected severity of TB outbreaks. Predictions showed that an HIV epidemic can significantly increase frequency and severity of TB outbreaks, but that this amplification effect of HIV on outbreaks is very sensitive to the TB treatment rate.

Author: Small, Peter M., Porco, Travis C., Blower, Sally M.
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2001
Prevention, Tuberculosis, Epidemics

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Long-term impact of IL-2 therapy on HIV infection. Immunologic and virologic consequences

Article Abstract:

The immunologic and virologic consequences and long-term impact of intermittent interleukin (IL) 2 therapy on HIV infection is discussed. It is concluded that the correlates of IL-2-induced immunologic reconstitution, in addition to the restoration of a normal number of circulating CD4 T-cells remain to be fully uncovered.

Author: Poli, Guido
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2006
Research and Development in the Physical, Engineering, and Life Sciences, Science & research, Immunology, Interleukin-2

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, United States, Physiological aspects, HIV infection, HIV infections, AIDS (Disease), AIDS research
Similar abstracts:
  • Abstracts: Association of the auscultatory gap with vascular disease in hypertensive patients. Obesity and hypertension: what should we do?
  • Abstracts: Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Immune privilege or inflammation: insights into the fas ligand enigma
  • Abstracts: Metabolic issues associated with protease inhibitors. Eradication of cryptosporidia and microsporidia following successful antiretroviral therapy
  • Abstracts: Dental considerations for the patient with renal disease receiving hemodialysis. The dental patient with asthma: an update and oral health considerations
  • Abstracts: Effect of the interval between pregnancies on perinatal outcomes. Effect of the interval between pregnancies on perinatal outcomes among white and black women
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.